SKLICE Drug Patent Profile
✉ Email this page to a colleague
When do Sklice patents expire, and when can generic versions of Sklice launch?
Sklice is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in SKLICE is ivermectin. There are five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sklice
A generic version of SKLICE was approved as ivermectin by EDENBRIDGE PHARMS on October 24th, 2014.
Summary for SKLICE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 5 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SKLICE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SKLICE |
What excipients (inactive ingredients) are in SKLICE? | SKLICE excipients list |
DailyMed Link: | SKLICE at DailyMed |
Recent Clinical Trials for SKLICE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
City of Hope Medical Center | Phase 2 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
Pharmacology for SKLICE
Drug Class | Antiparasitic Pediculicide |
Anatomical Therapeutic Chemical (ATC) Classes for SKLICE
Paragraph IV (Patent) Challenges for SKLICE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SKLICE | Lotion | ivermectin | 0.50% | 202736 | 1 | 2017-09-01 |
US Patents and Regulatory Information for SKLICE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SKLICE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SKLICE
See the table below for patents covering SKLICE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2719200 | ⤷ Try a Trial | |
Taiwan | I474841 | ⤷ Try a Trial | |
Canada | 2666365 | FORMULATIONS TOPIQUES D'AVERMECTINE ET PROCEDES D'ELIMINATION ET DE PROPHYLAXIE DE SOUCHES DE POUX SUSCEPTIBLES ET RESISTANTES AU TRAITEMENT (TOPICAL AVERMECTIN FORMULATIONS AND METHODS FOR ELIMINATION AND PROPHYLAXIS OF SUSCEPTIBLE AND TREATMENT-RESISTANT STRAINS OF HEAD LICE) | ⤷ Try a Trial |
Mexico | 2011004442 | SISTEMA CONSERVANTE PARA FORMULACIONES TOPICAS TERAPEUTICAS BASADAS EN EMULSION. (PRESERVATIVE SYSTEM FOR EMULSION-BASED THERAPEUTIC TOPICAL FORMULATIONS.) | ⤷ Try a Trial |
Canada | 2686336 | FORMULATIONS TOPIQUES ET PROCEDES D'ELIMINATION ET DE PROPHYLAXIE DE SOUCHES DE POUX SUSCEPTIBLES ET RESISTANTES AU TRAITEMENT AVEC DE MULTIPLES MODES D'ACTION (TOPICAL FORMULATIONS AND METHODS FOR ELIMINATION AND PROPHYLAXIS OF SUSCEPTIBLE AND TREATMENT RESISTANT STRAINS OF HEAD LICE WITH MULTIPLE MODES OF ACTION) | ⤷ Try a Trial |
New Zealand | 700972 | Preservative system for emulsion-based therapeutic topical formulations | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SKLICE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1620113 | 92915 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE POUR SON USAGE DANS LE TRAITEMENT DE LA ROSACEA; FIRST REGISTRATION: 20150402 |
1620113 | 122015000079 | Germany | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN ZU SEINER VERWENDUNG FUER DIE BEHANDLUNG VON ROSAZEA; NAT. REGISTRATION NO/DATE: 92429.00.00 20150429; FIRST REGISTRATION: MALTA MA 117/01101 20150402 |
1620113 | C 2015 036 | Romania | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINA; NATIONAL AUTHORISATION NUMBER: RO7674/2015/01, RO7674/2015/02, RO7674/2015/03, RO7674/2015/04, RO7674/2015/05; DATE OF NATIONAL AUTHORISATION: 20150526; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): MALTA MA117/01101; DATE OF FIRST AUTHORISATION IN EEA: 20150402 |
1620113 | 56/2015 | Austria | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN; NAT. REGISTRATION NO/DATE: 136170 20150602; FIRST REGISTRATION: MT MA 117/01101 20150402 |
1620113 | 15C0069 | France | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE; NAT. REGISTRATION NO/DATE: NL 44511 20150721; FIRST REGISTRATION: MT - MA 117/01101 20150402 |
1620113 | CA 2015 00045 | Denmark | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN, 22, 23-DIHYDROAVERMECTINB1A + 22,23-DIHRODROAVERMECTIN B1B FOR USE IN THE TREATMNET OF RESACEA; NAT. REG. NO/DATE: 54123 20150422; FIRST REG. NO/DATE: MT MA 117/01101 20150402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |